16 Oct 2018

DRUGMAKERS FUNNEL MILLIONS TO LAWMAKERS; A FEW DOZEN GET $100,000-PLUS

  By Emmarie Huetteman and Sydney Lupkin Before the midterm elections heated up, dozens of drugmakers had already poured about $12 million into the war chests of hundreds of members of Congress. Since the beginning of last year, 34 lawmakers have each received more than $100,000 from pharmaceutical companies. Two

0
16 Oct 2018

CMS PROPOSAL TO REQUIRE MANUFACTURERS TO DISCLOSE DRUG PRICES IN TV ADS COMMENTS DUE BY DEC. 17

  The Centers for Medicare & Medicaid Services proposed Oct. 15 to require that prescription drug manufacturers post the Wholesale Acquisition Cost (WAC) for drugs covered in Medicare or Medicaid in direct-to-consumer television advertisements. “This historic proposal is an important way to create new incentives for drug companies to start

0
16 Oct 2018

TELEMEDICINE GIANT HEALTHRIGHT, 4 COMPOUNDING PHARMACIES CHARGED WITH $1 BILLION FRAUD

  HealthRight CEO Scott Roix of the telemedicine company HealthRight pleaded guilty to felony conspiracy charges brought by the Department of Justice. Roix and the company also pleaded guilty to conspiring to commit wire fraud associated with a telemarketing scheme to sell dietary supplements, skin creams and testosterone to patients. Roix and the

0
09 Oct 2018

CMS ANNOUNCES PARTICIPANTS IN NEW VALUE-BASED BUNDLED PAYMENT MODEL

  On Oct. 9, the Centers for Medicare & Medicaid Services (CMS) announced that 1,299 entities have signed agreements with the agency to participate in the Administration’s Bundled Payments for Care Improvement – Advanced (BPCI Advanced) Model.  The participating entities will receive bundled payments for certain episodes of care as

0
28 Sep 2018

SEEMA VERMA SPEECH: CMS TO BEGIN AUDITS ON MEDICAID INSURERS

Seema Verma, Centers for Medicare & Medicaid Services Administrator, issued a warning to Medicaid plan sponsors on Thursday, warning the agency would begin unscheduled targeted financial audits. The warning came at the 2018 Medicaid Managed Care Summit during a speech Verma delivered in which she vowed to bring more transparency to

0
27 Sep 2018

SPEECH: CMS ADMINISTRATOR SEEMA VERMA’S REMARKS AT THE 2018 MEDICAID MANAGED CARE SUMMIT SEPT. 27

It is great to be back in front of a room full of professionals dedicated to improving the lives of Medicaid beneficiaries. For me, it’s a little like coming home. I see the faces of the people out working on the front lines, of transforming the American health care system,

0
29 Aug 2018

MEDICAL GROUPS, PATIENT ADVOCATES OPPOSE MEDICARE PLANS TO CONSOLIDATE E/M CODES

More than 150 medical groups sent a letter opposing a government plan to consolidate evaluation and management (E/M) codes, saying it could underpay doctors who treat the sickest patients. In a letter sent to Seema Verma, administrator of the Centers for Medicare & Medicaid Services, the groups — including the American Medical Association

0
27 Aug 2018

CIGNA, EXPRESS SCRIPTS SHAREHOLDERS APPROVE PURCHASE OF THE PBM; CLOSE EXPECTED BY YEAR’S END

  Cigna and Express Scripts shareholders approved the insurer’s $67 billion acquisition of the pharmacy benefit manager in late August. The deal still has to pass a review by the Department of Justice, but the companies said they expect it to close by the end of the year. The deal

0
13 Aug 2018

ENOUGH IS ENOUGH: MEDICAL GROUPS DEMAND HHS STOP STALLING ON INFORMATION BLOCKING

                Enough is enough. The American Academy of Family Physicians (AAFP) joined 13 other medical associations and healthcare organizations Aug. 9 in telling the federal government it has dragged out the regulation-writing process on an important topic far too long. At issue are the information blocking provisions of the 21st Century

0
10 Aug 2018

GLOBAL ULTRASOUND DEVICES MARKET ANALYZED THROUGH 2023

           A global ultrasound devices market report has added to the Research and Markets  offering. According to the “Global Ultrasound Devices Market — Segmented by Application, Technology, Type, and Geography – Growth, Trends, and Forecast (2018-2023)” report, the market is expected to register a CAGR of about 4 percent during 2018-2023. The

0